The tobacco budworm, Chloridea (Heliothis) virescens (F.), has evolved resistance to numerous insecticides in the field. In tobacco, chlorantraniliprole can be applied as either a preventative systemic soil application at or near transplant, or a foliar application timed to current treatment thresholds. With a novel mode of action chlorantraniliprole provides an option for rotation with other insecticides to reduce the probability of insecticide resistance development. However, specific usage patterns in tobacco have the potential to increase the risk of resistance development to this insecticide. In particular, soil applied treatments may expose C. virescens to sublethal concentrations of the insecticide. We studied chlorantraniliprole susceptibility in nine field populations and one laboratory strain of C. virescens using a diet incorporation bioassay. Mortality was measured at 7, 10, and 14 d after exposure. Our results demonstrated that bioassays should be evaluated at 14 d after exposure to optimize interpretation of the dose–response due to the antifeeding properties of chlorantraniliprole. We observed low variation within field-collected populations. Field populations were as susceptible as the laboratory strain; the resistance ratio at the 14-d evaluation for field-collected populations ranged from 1.01 to 1.05. A discriminating dose of 0.117, 0.080, and 0.070 µg a.i./g diet could be used at 7, 10, and 14 d, respectively. Larval growth varied between field populations. Two field populations continued growing on diet containing chlorantraniliprole and differed in size from the laboratory and other populations. Further evaluation of growth inhibition will be necessary.
You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither BioOne nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the BioOne website.
Vol. 114 • No. 3